Lichen Planus Treatment in Kuwait
Lichen planus is an immune-mediated condition affecting about 1% of people, and the skin rash usually settles within nine to eighteen months. What tends to outlast it is the pigmentation — and in brown skin that mark is darker and stays far longer than the rash that caused it.
What you should know
- Lichen planus affects about 1% of the population worldwide, most often adults between thirty and sixty. It is immune-mediated and not contagious at all — it does not spread by contact or by sharing items.
- The characteristic sign is Wickham striae: a network of fine white lines over flat-topped, polygonal, violet papules, most often on the wrists, lower back and ankles.
- It goes beyond the skin: around 50% of patients have oral involvement and about 10% have nail involvement. Scalp involvement causes permanent scarring hair loss, and nails can be permanently scarred too.
- The natural history differs by site: the skin rash usually settles within 9 to 18 months and may run to two years, whereas mucosal disease in the mouth or genitals often persists for a decade or longer.
- For Fitzpatrick skin types III to V: as the rash resolves it leaves greyish-brown macules over some months, and hypertrophic and actinic variants along with post-inflammatory hyperpigmentation are commoner in darker skin. Lichen planus pigmentosus is a distinct pattern seen particularly in Middle Eastern and South Asian patients — slate-grey to brownish-black patches on the face and neck that can persist for decades.
- Look for a trigger in widespread disease: lichen planus is associated with hepatitis C, and lichenoid drug eruptions can be caused by gold, quinine, quinidine, hydroxychloroquine and captopril. Reviewing your medication list can change the whole plan.
Treatment options
- Potent topical corticosteroids are first line for cutaneous lichen planus, aimed at settling inflammation and itch quickly so that less pigment is left behind. Thick hypertrophic plaques respond better to intralesional corticosteroid injection.
- Topical calcineurin inhibitors such as tacrolimus and pimecrolimus are useful on the face, genital skin and oral mucosa, where prolonged steroid use is undesirable because of skin thinning.
- Phototherapy is a reasonable option for widespread disease that is impractical to cover with ointment, and is also used when topical treatment fails.
- For severe or resistant disease, systemic drugs are used: oral corticosteroid courses of one to three months, or acitretin, hydroxychloroquine, methotrexate, azathioprine or mycophenolate. All require periodic laboratory monitoring.
- Residual pigment must be treated as a separate problem from inflammation: in lichen planus pigmentosus many agents have been tried with little or no benefit. Effort therefore goes into stopping active inflammation early and strict sun protection, rather than attempting rapid lightening.
The most important distinction in this condition is between inflammation and pigmentation. Treatment controls the inflammation and itch within weeks, but it does not erase the dark marks left behind; those fade very slowly over months to years, and in lichen planus pigmentosus can persist for decades. So the real gain from treating early is not lightening what has already happened — it is preventing new pigment from forming. More importantly still: damage to the scalp and nails is scarring and permanent once it occurs, which is why hair or nail involvement deserves prompt review rather than watchful waiting.
Frequently asked questions
Is lichen planus contagious?
No, it is not contagious in any way. It does not spread by shaking hands, sharing towels or utensils, or through intimacy, because it is an immune response directed against skin and mucous membrane cells rather than an infection. Nor is it directly inherited, although a familial tendency is occasionally observed.
Does lichen planus come back after it clears?
In most people it does not return once the skin rash has cleared, but some patients have recurrent episodes separated by months or years. Mucosal and nail forms are more likely to persist or recur than the skin rash. If it does return, that does not mean the earlier treatment failed — it is a reason to look again for a drug or other trigger.
Does oral lichen planus cause cancer?
The risk is real but small. In a pooled analysis of 54 studies and 24,277 patients, the malignant transformation rate for oral lichen planus was 0.94%, and 1.07% for oral lichenoid conditions overall. Risk is higher with red lesions, in smokers, in those who drink alcohol, and in people with hepatitis C. Practically that means periodic oral review and stopping smoking — not permanent anxiety.
When will the dark marks left by the rash fade?
Slowly — and that is the honest answer. Greyish-brown marks fade gradually over months to years once the inflammation has settled, and they are more visible and longer-lasting in brown skin. In lichen planus pigmentosus on the face and neck, pigmentation can persist for decades, and many treatments have been tried for it with little benefit. Daily sun protection is what helps most in stopping it from deepening.
Book an appointment
My private clinic at Kuwait Hospital (Sabah Al-Salem) — direct assessment and a treatment plan built around your case.
Book on WhatsAppPatient advice sheets
Short, practical sheets to read before or after your visit.